S-1 · primary offering
Issued 2026
Proposed maximum
Shares registered
- Filed
- Effective
Sector: Pharmaceutical PreparationsIndustry: Shell CompaniesCountry: USExchange: Nasdaq
DilutionScan read 20 of Research Alliance Corp III's SEC filings and found 1 warrant series, 1 convertible, 1 S-1 registration and 3 completed offerings on file for RACC. The latest dilution event on file is an offering on May 21, 2026. Analysis updated Nov 16, 2026.
Raise routes on file: no active ATM, effective shelf, issuer S-1 or active equity line in the filings read · latest dilution event 180 days ago
The dominant contractual driver and its mechanism, then each further driver ranked.
May 21, 2026 · Offering
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
From $29.99/mo. Signal8 Pro is $49/mo, or $40.67/mo billed yearly ($488/yr)
Shares outstanding, potential dilution and cash over time
Issued 2026
Proposed maximum
Shares registered
Shares Underlying
Exercise Price
Principal
Conversion Price
Issued 2026
Gross proceeds
Price per share
Issued 2026
Gross proceeds
Price per share
Issued 2026
Gross proceeds
Price per share
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
From $29.99/mo. Signal8 Pro is $49/mo, or $40.67/mo billed yearly ($488/yr)
DilutionScanEvery instrument in full · From $29.99/mo
Covered companies in Shell Companies. All tickers A to Z